Monday, March 05, 2018 10:15 PM ET
Insider buy at OPKO Health (OPK) Extends the Trend of purchases over Last Quarter
There was a significant insider purchase in OPKO Health shares today as revealed in a filing with the SEC. One insider — Dr Phillip Frost, 10% Owner, Director and Officer — bought 364,800 shares in the company having a net market value of approximately $1,073,716. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the purchase of 1,115,500 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net purchases of 1,480,300 shares and have averaged 740,150 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at OPKO Health is higher than the 121-company peer group average. Pharmaceuticals peer group saw 67 buy/sell trades during this period for an average of 0.6 transactions per company. The number of shares per buy/sell trade for OPKO Health insiders was also higher. Within the peer group there were 2,129,599 shares purchased and 3,942,668 shares sold with company insiders selling 27,061 shares on average.
Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in composing and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2018 UpTick Data Technologies. All rights reserved.